Amedisys Management
Management criteria checks 3/4
Amedisys' CEO is Richard Ashworth, appointed in Apr 2023, has a tenure of 2.08 years. total yearly compensation is $7.60M, comprised of 13.5% salary and 86.5% bonuses, including company stock and options. directly owns 0.071% of the company’s shares, worth €2.01M. The average tenure of the management team and the board of directors is 2.1 years and 5.5 years respectively.
Key information
Richard Ashworth
Chief executive officer
US$7.6m
Total compensation
CEO salary percentage | 13.47% |
CEO tenure | 2.1yrs |
CEO ownership | 0.07% |
Management average tenure | 2.1yrs |
Board average tenure | 5.5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Mar 31 2025 | n/a | n/a | US$90m |
Dec 31 2024 | US$8m | US$1m | US$43m |
Sep 30 2024 | n/a | n/a | US$83m |
Jun 30 2024 | n/a | n/a | US$92m |
Mar 31 2024 | n/a | n/a | -US$21m |
Dec 31 2023 | US$17m | US$692k | -US$10m |
Compensation vs Market: Richard's total compensation ($USD7.60M) is above average for companies of similar size in the German market ($USD2.23M).
Compensation vs Earnings: Richard's compensation has been consistent with company performance over the past year.
CEO
Richard Ashworth (49 yo)
2.1yrs
Tenure
US$7,603,054
Compensation
Mr. Richard M. Ashworth is serving as Director of Rite Aid Corporation from December 2024. He served as Director at Tivity Health, Inc. since June 1, 2020 until April 2023 and had been its President since...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 2.1yrs | US$7.60m | 0.071% € 2.0m | |
Executive VP | 7.6yrs | US$3.41m | 0.094% € 2.6m | |
Chief Legal Officer & Corporate Secretary | 9.3yrs | US$1.04m | 0.022% € 621.9k | |
Chief Compliance Officer | 5.7yrs | US$1.40m | 0.029% € 816.2k | |
Chief Strategy Officer | no data | US$2.71m | 0.0099% € 278.4k | |
Chief Accounting Officer & Principal Accounting Officer | 1.8yrs | no data | 0.025% € 697.4k | |
CTO & Senior VP of Business Operations Systems | no data | no data | no data | |
Acting Chief Information Officer | less than a year | no data | no data | |
VP of Marketing & Communications & Media Relations | no data | no data | no data | |
Acting Chief People Officer | less than a year | no data | no data | |
Senior Vice President of Development | no data | no data | no data |
2.1yrs
Average Tenure
46yo
Average Age
Experienced Management: ADY's management team is considered experienced (2.1 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 2.1yrs | US$7.60m | 0.071% € 2.0m | |
Chairman | 10.4yrs | US$354.51k | 1.34% € 37.8m | |
Independent Director | 10.1yrs | US$269.51k | 0.068% € 1.9m | |
Independent Director | 5.5yrs | US$279.51k | 0.025% € 698.6k | |
Independent Director | 5.5yrs | US$269.51k | 0.022% € 612.6k | |
Lead Independent DIrector | 9.1yrs | US$284.51k | 0.044% € 1.2m | |
Independent Director | 9.1yrs | US$269.51k | 0.023% € 656.8k | |
Independent Director | 5.5yrs | US$274.51k | 0.025% € 698.6k | |
Independent Director | 4.4yrs | US$254.51k | 0.018% € 507.9k |
5.5yrs
Average Tenure
63yo
Average Age
Experienced Board: ADY's board of directors are considered experienced (5.5 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/05/12 05:37 |
End of Day Share Price | 2025/05/12 00:00 |
Earnings | 2025/03/31 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Amedisys, Inc. is covered by 31 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Brian Hoffman | Avondale Partners |
Matthew Gillmor | Baird |
Steven Valiquette | Barclays |